Monitoring investigation | Lithium testing percentage at 6 months, 1 year and testing frequency (n = 164) | Carbamazepine (n = 6) | Valproate (n = 119) | Newer antipsychotics (n = 151) |
---|---|---|---|---|
Serum drug concentration | 75 (45.7%) in last 6 months | ND | ND | NR |
96 (58.5%) in the last year | ||||
Frequency – once in 13 months | ||||
Serum Creatinine/ urea | 30 (18.3%) in the last 6 months | 1 record in the last year | NR | NR |
39 (23.8%) in the last year | ||||
Frequency – once in 33 months | ||||
Full Blood Count (FBC) | NR | 1 record in the last year | 9 (7.6%) in the last year | NR |
Electrolytes | 34 (20.7%) in the last year | 1 record in the last year | NR | NR |
Frequency – once in 5 years | ||||
TSH | 30 (18.3%) in the last year | NR | NR | NR |
Frequency – once in 5 ½ years | ||||
Serum Calcium | ND | NR | NR | NR |
Liver function tests | NR | ND | 19 (16%) in the last year | NR |
Fasting blood glucose | NR | NR | 23 (19.3%) in the last year | 31 (20.5%) in the last year |
Fasting lipid profile | NR | NR | 14 (11.8%) in the last year | 13 (8.6%) in the last year |